US2011039928A1PendingUtilityA1
Cetylated fatty acid and alkali buffered creatine anti-inflammatory composition
Individually held — no corporate assignee on recordPriority: Aug 13, 2009Filed: Aug 12, 2010Published: Feb 17, 2011
Est. expiryAug 13, 2029(~3 yrs left)· nominal 20-yr term from priority
Inventors:Jeffrey M. Golini
A61K 31/23A61K 31/197A61K 31/231A61P 29/00
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An anti-inflammatory composition for treatment of inflamed joints. This composition includes an alkali buffered creatine and a cetylated fatty acid. The composition can be used for treating inflammation either by oral ingestion or by topical treatment.
Claims
exact text as granted — not AI-modifiedI claim:
1 . An anti-inflammatory creatine composition comprising an alkali buffered creatine and a cetylated fatty acid.
2 . The composition according to claim 1 wherein the cetylated fatty acid includes at least one of cetyl myristoleate, cetyl mylistate, cetyl palmitoleate, cetyl laureate, cetyl plamitate and cetyl oleate.
3 . The composition according to claim 1 formed in a solid form capable of ingestion.
4 . The composition according to claim 3 wherein the solid form is configured as at least one of a food supplement, a tablet, a granule and a capsule.
5 . The composition according to claim 1 formed in a liquid form capable of ingestion.
6 . The composition according to claim 1 suitable for being received by topical application.
7 . The composition according to claim 6 suitable for being received by at least one of a suspension, an emulsion and a solution.
8 . The composition according to claim 7 which is configured as at least one of an ointment, lotion, cream and gel.Join the waitlist — get patent alerts
Track US2011039928A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.